Table 2.

Clinical and Radiologic Findings of Patients With Rare Pneumocystis jirovecii Detected by PCR

Immunocompromising Condition/Therapy, n (%)	Presence and Type of Pulmonary Infiltrates, n (%)	Pathology/Laboratory Findings, n	Clinically Recognized and Treated, n (%)	Associated Mortality, n (%)
15/19 (78.9)	Pulmonary infiltrates: 17/19 (89.5) Bilateral infiltrates: 16/17 (94.1) CT scan performed: 14/19 (73.7) Ground glass infiltrates: 14/14 (100)	Cytology: 0/9 detected Surg. path: 1/3 detected Other pathogens detected:  Influenza A: 1  S. pneumoniae: 2  CMV: 1  MAC: 1	18/19 (94.7)	4/19 (21.5) Direct mortality: 1/4 Contributory (comorbid condition): 3/4

Abbreviations: CMV, ; CT, computerized tomography; MAI, ; PCR, polymerase chain reaction.